postprandial hypoglycemia) and mixed meal tolerance test (to assess postprandial hypoglycemia and corresponding insulin levels)
VE, NO, PC, VF, MC, MCS and JD executed immunohistochemistry experiments
News about GLP-1s A Fifth Circuit panel is reviewing whether the FDA properly removed two blockbuster weight-loss drugs, Wegovy and Zepbound, from its shortage list, effectively banning compounding pharmacies from making cheaper versions
Statistics Statistical analyses were performed with GraphPad Prism 8 software (La Jolla, CA, USA)
One possible way to minimize the side-effects of the single drugs is to combine them to achieve synergistic effects, as reported recently with a combination of a DPP-IV inhibition, SSTR5 antagonism and GPR40 and TGR5 agonism, capable to raise circulatory active GLP-1(7-36) NH2 levels to more than 300-400 pM in mice (240)